NCT07584239
- Conditions
- Resectable Lung Non-Small Cell Carcinoma
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Resectable Lung Non-Small Cell Carcinoma
Explore clinical trials studying Resectable Lung Non-Small Cell Carcinoma. Study availability and eligibility vary by location and protocol.
11 public trials
7 recruiting studies
Resectable Lung Non-Small Cell Carcinoma trial results
NCT06431633
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Hospital General Universitario de Alicante Alicante, Spain
- Hospital General de Elche Elche, Alicante, Spain
- ICO Badalona, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
- Hospital Universitari Vall d' Hebron Barcelona, Spain
Recruiting
Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +83 more
- Locations
-
- Mayo Clinic in Arizona Phoenix, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT06008730
- Conditions
- Resectable Lung Non-Small Cell Carcinoma
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT06276530
- Conditions
- Resectable Lung Non-Small Cell Carcinoma
- Locations
-
- Department of Thoracic and Vascular Surgery Tenon University Hospital Paris, France
NCT06775275
- Conditions
- Resectable Lung Non-Small Cell Carcinoma
- Locations
-
- Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University Guangzhou, China
NCT06241807
- Conditions
- Biomarkers / Blood, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- Shandong Cancer Hospital and Institute Jinan, Shandong, China
Not yet recruiting
Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE Trial
NCT07746388
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
Not specified
Not yet recruiting
High-Dose Firmonertinib Plus Bevacizumab as Neoadjuvant Therapy for Resectable EGFRm Stage II-IIIB NSCLC
NCT07182708
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Active, not recruiting
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
NCT06632327
- Conditions
- Lung Diseases, Lung Neoplasms, Neoplasms, +8 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States